|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ahnen DJ, Wade SW, Jones WF, Sifri R,
Mendoza Silveiras J, Greenamyer J, Guiffre S, Axilbund J, Spiegel A
and You YN: The increasing incidence of young-onset colorectal
cancer: A call to action. Mayo Clin Proc. 89:216–224. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ladabaum U, Dominitz JA, Kahi C and Schoen
RE: Strategies for colorectal cancer screening. Gastroenterology.
158:418–432. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Uszczynska-Ratajczak B, Lagarde J,
Frankish A, Guigó R and Johnson R: Towards a complete map of the
human long non-coding RNA transcriptome. Nat Rev Genet. 19:535–548.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Davalos V and Esteller M: Disruption of
long noncoding RNAs targets cancer hallmark pathways in lung
tumorigenesis. Cancer Res. 79:3028–3030. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu F, Sui Y, Wang Y, Xu T, Fan L and Zhu
H: Long noncoding RNA SNHG7, a molecular sponge for microRNA-485,
promotes the aggressive behavior of cervical cancer by regulating
PAK4. Onco Targets Ther. 13:685–699. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang S, Ding L, Gao F and Fan H: Long
non-coding RNA DSCAM-AS1 upregulates USP47 expression through
sponging miR-101-3p to accelerate osteosarcoma progression. Biochem
Cell Biol. 98:600–611. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang R, Huang Z, Qian C, Wang M, Zheng Y,
Jiang R and Yu C: LncRNA WEE2-AS1 promotes proliferation and
inhibits apoptosis in triple negative breast cancer cells via
regulating miR-32-5p/TOB1 axis. Biochem Biophys Res Commun.
526:1005–1012. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fang Y, Zhang S, Yin J, Shen YX, Wang H,
Chen XS and Tang H: LINC01535 promotes proliferation and inhibits
apoptosis in esophageal squamous cell cancer by activating the
JAK/STAT3 pathway. Eur Rev Med Pharmacol Sci. 24:3694–3700.
2020.PubMed/NCBI
|
|
10
|
Yan Z, Zhang W, Xiong Y, Wang Y and Li Z:
Long noncoding RNA FLVCR1-AS1 aggravates biological behaviors of
glioma cells via targeting miR-4731-5p/E2F2 axis. Biochem Biophys
Res Commun. 521:716–720. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yan H, Li H, Silva MA, Guan Y, Yang L, Zhu
L, Zhang Z, Li G and Ren C: LncRNA FLVCR1-AS1 mediates miR-513/YAP1
signaling to promote cell progression, migration, invasion and EMT
process in ovarian cancer. J Exp Clin Cancer Res. 38:3562019.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lin H, Shangguan Z, Zhu M, Bao L, Zhang Q
and Pan S: lncRNA FLVCR1-AS1 silencing inhibits lung cancer cell
proliferation, migration, and invasion by inhibiting the activity
of the Wnt/β-catenin signaling pathway. J Cell Biochem.
120:10625–10632. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Luo H, Xu C, Le W, Ge B and Wang T: lncRNA
CASC11 promotes cancer cell proliferation in bladder cancer through
miRNA-150. J Cell Biochem. 120:13487–13493. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Peng CL, Zhao XJ, Wei CC and Wu JW: LncRNA
HOTAIR promotes colon cancer development by down-regulating
miRNA-34a. Eur Rev Med Pharmacol Sci. 23:5752–5761. 2019.PubMed/NCBI
|
|
15
|
Lai XJ and Cheng HF: LncRNA colon
cancer-associated transcript 1 (CCAT1) promotes proliferation and
metastasis of ovarian cancer via miR-1290. Eur Rev Med Pharmacol
Sci. 22:322–328. 2018.PubMed/NCBI
|
|
16
|
Wang C, Huang Y, Zhang J and Fang Y:
MiRNA-339-5p suppresses the malignant development of gastric cancer
via targeting ALKBH1. Exp Mol Pathol. 115:1044492020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hong YG, Huang ZP, Liu QZ, E JF, Gao XH,
Xin C, Zhang W, Li P and Hao LQ: MicroRNA-95-3p inhibits cell
proliferation and metastasis in colorectal carcinoma by HDGF.
Biomed J. 43:163–173. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen Y, Zhou J, Wu X, Huang J, Chen W, Liu
D, Zhang J, Huang Y and Xue W: MiR-30a-3p inhibits renal cancer
cell invasion and metastasis through targeting ATG12. Transl Androl
Urol. 9:646–653. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shang A, Zhou C, Bian G, Chen W, Lu W,
Wang W and Li D: miR-381-3p restrains cervical cancer progression
by downregulating FGF7. J Cell Biochem. 120:778–789. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xie Y, Qi J, Zhu C, Zhao D and Liao G:
MiR-381 functions as a tumor suppressor in gastric cancer by
targeting ROCK2. Int J Clin Exp Pathol. 12:164–172. 2019.PubMed/NCBI
|
|
21
|
Hu J, Wu X, Yang C, Rashid K, Ma C, Hu M,
Ding Q and Jiang H: Anticancer effect of icaritin on prostate
cancer via regulating miR-381-3p and its target gene UBE2C. Cancer
Med. 8:7833–7845. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
He X, Wei Y, Wang Y, Liu L, Wang W and Li
N: MiR-381 functions as a tumor suppressor in colorectal cancer by
targeting Twist1. Onco Targets Ther. 9:1231–1239. 2016.PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bao W, Cao F, Ni S, Yang J, Li H, Su Z and
Zhao B: lncRNA FLVCR1-AS1 regulates cell proliferation, migration
and invasion by sponging miR-485-5p in human cholangiocarcinoma.
Oncol Lett. 18:2240–2247. 2019.PubMed/NCBI
|
|
25
|
Liu Y, Guo G, Zhong Z, Sun L, Liao L, Wang
X, Cao Q and Chen H: Long non-coding RNA FLVCR1-AS1 sponges miR-155
to promote the tumorigenesis of gastric cancer by targeting c-Myc.
Am J Transl Res. 11:793–805. 2019.PubMed/NCBI
|
|
26
|
Gao X, Zhao S, Yang X, Zang S and Yuan X:
Long non-coding RNA FLVCR1-AS1 contributes to the proliferation and
invasion of lung cancer by sponging miR-573 to upregulate the
expression of E2F transcription factor 3. Biochem Biophys Res
Commun. 505:931–938. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang L, Cheng H, Yue Y, Li S, Zhang D and
He R: TUG1 knockdown ameliorates atherosclerosis via up-regulating
the expression of miR-133a target gene FGF1. Cardiovasc Pathol.
33:6–15. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Riaz F and Li D: Non-coding RNA associated
competitive endogenous RNA regulatory network: Novel therapeutic
approach in liver fibrosis. Curr Gene Ther. 19:305–317. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wu D, Qin BY, Qi XG, Hong LL, Zhong HB and
Huang JY: LncRNA AWPPH accelerates the progression of non-small
cell lung cancer by sponging miRNA-204 to upregulate CDK6. Eur Rev
Med Pharmacol Sci. 24:4281–4287. 2020.PubMed/NCBI
|
|
30
|
Wang X, Chen K and Zhao Z: LncRNA OR3A4
regulated the growth of osteosarcoma cells by modulating the
miR-1207-5p/G6PD Signaling. Onco Targets Ther. 13:3117–3128. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Meng Q, Wang L, Lv Y, Wu J and Shi W:
Deletion of HNF1A-AS1 suppresses the malignant phenotypes of breast
cancer cells in vitro and in vivo through targeting
miRNA-20a-5p/TRIM32 axis. Cancer Biother Radiopharm. Apr
22–2020.(Epub ahead of print). doi: 10.1089/cbr.2019.3168.
View Article : Google Scholar
|
|
32
|
Zhang J, Wei Y, Min J, Wang Y, Yin L, Cao
G and Shen H: Knockdown of RAP2A gene expression suppresses
cisplatin resistance in gastric cancer cells. Oncol Lett.
19:350–358. 2020.
|
|
33
|
Zheng X, Zhao W, Ji P, Zhang K, Jin J,
Feng M, Wang F, Zheng S and Wang X: High expression of Rap2A is
associated with poor prognosis of patients with hepatocellular
carcinoma. Int J Clin Exp Pathol. 10:9607–9613. 2017.PubMed/NCBI
|
|
34
|
Wu JX, Du WQ, Wang XC, Wei LL, Huo FC, Pan
YJ, Wu XJ and Pei DS: Rap2a serves as a potential prognostic
indicator of renal cell carcinoma and promotes its migration and
invasion through up-regulating p-Akt. Sci Rep. 7:66232017.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wu JX, Zhang DG, Zheng JN and Pei DS:
Rap2a is a novel target gene of p53 and regulates cancer cell
migration and invasion. Cell Signal. 27:1198–1207. 2015. View Article : Google Scholar : PubMed/NCBI
|
